Letter to the Editor in response to “Response to Kovanen PT, et al. Letter to the Editor” for original article COVID-19 increases risk of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD

Letter to the Editor in response to “Response to Kovanen PT, et al. Letter to the Editor” for original article COVID-19 increases risk of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD

Bibliographic Details
Main Authors:	Kelly D. Myers, Katherine Wilemon, Mary P. McGowan, William Howard, David Staszak, Daniel J. Rader
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	American Journal of Preventive Cardiology
Subjects:	Familial Hypercholesteroleima FH ASCVD
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666667721000805

Similar Items

Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
by: Maria Mytilinaiou, et al.
Published: (2018-07-01)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
by: Chen CC, et al.
Published: (2018-12-01)

Chinese ASCVD risk equations rather than pooled cohort equations are better to identify macro- and microcirculation abnormalities
by: Qiaowei Li, et al.
Published: (2020-03-01)

COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
by: Kelly D. Myers, et al.
Published: (2021-09-01)

10-year ASCVD risk is positively correlated with depressive symptoms in a large general population
by: Guo-Zhe Sun, et al.
Published: (2019-04-01)

Expanding statin use for prevention of ASCVD in Indians: Reasoned and simplified proposals
by: Enas A. Enas, et al.
Published: (2020-03-01)

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
by: Hines DM, et al.
Published: (2018-12-01)

Response to Letter to the Editor
by: Clémence Gorlier, et al.
Published: (2020-04-01)

Response to the letter to editor
by: Yuji Tsutsui
Published: (2018-06-01)

Response to letter to the editor
by: Rosmin Esmail, et al.
Published: (2020-07-01)

Response to Letter to the Editor
by: Anindita Singha Roy MSc, et al.
Published: (2017-03-01)

Response to Letter to the Editor
by: Banu Bozkurt, et al.
Published: (2020-06-01)

Response to letter to the editor
by: Prakas Humar Mandal
Published: (2020-01-01)

Response to letter to the editor
by: Tom A.P. Driedonks, et al.
Published: (2019-12-01)

Response to ′Letter to Editor′
by: Bilal Ergül, et al.
Published: (2015-01-01)

Response to letter to the editor
by: Abrahão Elias Hallack Neto, et al.
Published: (2011-01-01)

Response to letter to the editor
by: Yu-Ting Chen, et al.
Published: (2020-08-01)

RESPONSE TO LETTER TO THE EDITOR
by: Shailendra Kapoor, et al.

Response to letter to the editor
by: L. G. Rikkert, et al.
Published: (2019-12-01)

Response to Letter to the Editor
by: Hsin-Fu Lee, et al.
Published: (2018-05-01)

Response to the letter to the editor
by: S A Jabeen, et al.
Published: (2016-01-01)

Response to: Letter to editor
by: Swapna A Mahale, et al.
Published: (2014-01-01)

Response to letter to the editor
by: Ana Paula Metran Nascente, et al.

Response to Letter to the Editor
by: Christian Bonde
Published: (2018-10-01)

Response to the letter to the editor
by: Nada Bennani Mechita, et al.
Published: (2021-03-01)

Response to letter to the editor
by: Ann Dadich, et al.
Published: (2021-08-01)

Association between Rutherford Classification and CHA2DS2-VASc, CHADS2 and ASCVD Scores in Peripheral Artery Disease Patients
by: Bilge Duran Karaduman, et al.
Published: (2020-05-01)

Response to the Letter to the Editor by Rob Armstrong
by: Robert H. Six, et al.
Published: (2017-04-01)

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
by: David I. Feldman, et al.
Published: (2020-12-01)

Letter to the Editor
by: Levan Göran, et al.
Published: (2006-06-01)

Author Response to Letter to the Editor
by: Jongmok Ha, et al.
Published: (2019-12-01)

Response to the Letter to the Editor by Harris
by: Telleasha L. Greay, et al.
Published: (2019-04-01)

Reader response: Letters to the Editor
by: DeFrain, Erica, et al.
Published: (2016)

Author Response to Letter to the Editor
by: Victoria Castrillo-Fraile, et al.
Published: (2020-02-01)

Letter to the Editor Regarding Vaping Article
by: Rabbi Yehuda Spitz
Published: (2019-10-01)

Letter to the Editor, International Journal of COPD [Response to Letter]
by: Llordés M, et al.
Published: (2020-10-01)

Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review
by: Matej Mlinaric, et al.
Published: (2020-10-01)

A Letter to the Editor on the Article by Farnam et al.—Author's Response
by: Farnam Farnaz, PhD, et al.
Published: (2015-09-01)

Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia
by: Praseetha Kizhakkedath, et al.
Published: (2019-11-01)

Letter to editorResponse from authors
by: Faizan Z. Kashoo, MPTh, et al.
Published: (2020-02-01)